Comparison of Efficacy, Safety and Tolerability of Two Different 810 nm Diode Lasers for Hair Reduction

January 7, 2016 updated by: Christopher Zachary, University of California, Irvine

Side-by-Side Comparison of 810 nm Diode Laser Technology With Low Fluence-High Repetition Rate vs Low Fluence-Vacuum Assist - A Split - Extremity Efficacy , Safety and Tolerability Study

The purpose of this research study is to compare two different 810 diode laser systems (Soprano XL (SHR Mode)and Light Sheer Duet) for laser hair removal. The goal is to determine if each laser system is effective at reducing the amount of hair on the lower legs or the axilla (arm pit). Another goal is determine the subject's perspective on the treatment including tolerability and effectiveness.

Study Overview

Status

Completed

Conditions

Detailed Description

This side-by-side split body, blinded, randomized single-center study is comparing two different 810 nm diode laser technologies for the purpose of permanent hair reduction to determine the effectiveness and subject's tolerance for hair reduction. Twenty volunteers will be enrolled into this study. Subjects will receive a total of 5 treatments of either axilla or lower legs. 10 patients will have both axilla treated while the other 10 subjects will have the lower legs treated. Placement to the axilla treatment group vs. the lower leg treatment group is random.

Treatment areas will be randomized to receive Soprano SHR treatment or Light Sheer/Duet treatment. One extremity (example: right axilla) will receive Soprano SHR treatment and the contra-lateral extremity (example: left axilla) will receive Duet treatment. The treatments will occur every 6 - 8 weeks and then there will be follow up visits at 1 month, 6 months, and 12 months after the last treatment.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Irvine, California, United States, 92697
        • Department of Dermatology Clinical Research

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Subjects must be at least 18 years of age.
  2. Subjects must be in reasonably good health as defined by the Investigator.
  3. Subject agrees to avoid tanning during their participation in this trial.
  4. Subject has Fitzpatrick skin types I-V and dark brown hair.
  5. Subjects must agree to avoid shaving legs less than 72 hours prior to a study visit.
  6. Subjects have indicated willingness to participate in the study by signing an informed consent document.

Exclusion Criteria:

  1. Subject is pregnant, lactating, or planning to get pregnant within the study period.
  2. Subject is unwilling to use birth control during the study period if of child bearing age.
  3. Subject has a known history of photosensitivity or use of medication with photosensitizing properties.
  4. Subject has skin disease on exam at screening.
  5. Subject has history or evidence of any chronic or reoccurring skin disease or disorder(e.g., psoriasis, Netherton syndrome, etc.) affecting the treatment area.
  6. Subject has a history of keloid or hypertrophic scar formation.
  7. Subject has a tattoo in the treatment area.
  8. Subject has been tanning within the past 30 days.
  9. Subject has history of confounding cancerous or pre-cancerous skin lesions in the treatment area.
  10. Subject has used prohibited therapies (electrolysis, threading, waxing, depilatory), prohibited oral prescription medications (isotretinoin, steroids), or prohibited topical meds (steroids) on the treatment area within 30 days prior to enrollment.
  11. Subject is unwilling to discontinue use of above listed prohibitive therapies for the duration of treatment.
  12. Subject has a history of laser hair removal in the treatment area.
  13. Subject has participated in any clinical trial involving an investigational drug or cosmetic product or procedure within the past 30 days.
  14. The investigator feels that for any reason the subject is not eligible to participate in the study.

    -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Soprano/SHR
Alma Soprano/SHR 810 nm Diode Laser
For the Soprano, the constant motion technique will be used with a fluence ranging between 6 J/cm2 and 10 J/cm2, 10 Hz, 20 ms pulse duration. The constant motion technique involves treating 100 cm2 areas with multiple passes until reaching the cumulative energy dose of 8 kJ. Thus, the hand piece is kept in constant motion to deliver continuous low fluence that will build up energy over time.
Other Names:
  • Soprano/SHR laser
Active Comparator: LightSheer
LightSheer Duet 810 nm diode laser
The LightSheer/Duet will be used with conventional single pass (stamping) of the handpiece using settings of single pulse fluence of up to 14 J/cm2 and low vacuum settings.
Other Names:
  • Duet LightSheer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Hair Growth
Time Frame: 1 month, 6 month, 12 month
% reduction from baseline hair count at time points 1 month, 6 months and 12 months [following last (5th laser) treatment]
1 month, 6 month, 12 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Rating Scale
Time Frame: 12 months
Pain during each treatment was measured subjectively by patients on a 0-10 visual analogue scale (0=no pain, 10=unbearable pain).
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christopher B Zachary, MBBS, FRCP, University of California, Irvine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

September 1, 2013

Study Registration Dates

First Submitted

September 22, 2010

First Submitted That Met QC Criteria

September 28, 2010

First Posted (Estimate)

September 30, 2010

Study Record Updates

Last Update Posted (Estimate)

February 5, 2016

Last Update Submitted That Met QC Criteria

January 7, 2016

Last Verified

October 1, 2015

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2010-7704

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertrichosis

Clinical Trials on Soprano/SHR

3
Subscribe